
Horizon Space Acquisition I Corp.
93
No recent company-specific business developments or announcements were identified in the recent news. Recent news items pertain to other companies and sectors.
Horizon Space Acquisition I Corp. operates as a special purpose acquisition company (SPAC) incorporated in the Cayman Islands in 2022. Its business model is to identify and complete a merger, share exchange, asset acquisition, or similar business combination with one or more target companies. The company raised approximately $70 million in its IPO and private placement, placing proceeds in a trust account to be used for the business combination or working capital. It has no operating revenue and has incurred losses related to formation and operating expenses. The company has extended its deadline multiple times to complete a business combination, with the latest extension to April 27, 2026. It terminated a prior business combination agreement in October 2025 by mutual consent. The company voluntarily delisted from Nasdaq in December 2025 and now trades on OTC markets under the ticker HSPOF. As of September 30, 2026, the company reported minimal current assets relative to current liabilities and a net loss for the period.
Horizon Space Acquisition I Corp. is a Cayman Islands exempted blank check company formed in 2022 to pursue a business combination. It completed an IPO in December 2022 raising approximately $70 million placed in a trust account. The company has no revenue and has incurred losses since inception. It has extended deadlines multiple times to complete a business combination, most recently to April 27, 2026, and terminated a prior business combination agreement in October 2025. The company voluntarily delisted from Nasdaq and trades OTC under HSPOF. As of September 30, 2026, it reported limited liquidity with a current ratio of 0.01 and a net loss of $117,601. Financial figures (if any) are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice. [S1][S2]
The company has secured approximately $70 million in trust funds from its IPO and private placement, providing capital to pursue a business combination. It has demonstrated flexibility by extending deadlines multiple times and managing working capital through unsecured promissory notes from the Sponsor. The termination of a prior business combination agreement was mutual and without penalty, indicating controlled risk management. The company’s Sponsor has shown commitment by funding extension fees and working capital loans, which may facilitate eventual transaction completion.
The company has not completed a business combination since its IPO in late 2022 and has repeatedly extended deadlines, indicating challenges in identifying or closing a suitable target. Its liquidity is limited, with a current ratio of 0.01 and cash ratio of 0.1 as of September 30, 2026, and it reported a net loss for the period. The voluntary delisting from Nasdaq to OTC markets may reduce investor visibility and liquidity. Failure to complete a business combination by the final deadline could lead to liquidation and dissolution, with potential loss of shareholder value.
As a blank check company, Horizon Space Acquisition I Corp. does not have an operating business or competitive moat. Its value depends on successfully identifying and completing a business combination with a target company. The company’s moat is limited to its ability to leverage its trust account funds and Sponsor relationships to consummate a transaction. The absence of revenue and reliance on extensions and working capital loans highlight the lack of intrinsic operational competitive advantages at this stage.
• Failure to Complete Business Combination: The company has repeatedly extended deadlines to complete a business combination. Failure to consummate a transaction by the final deadline may require liquidation and dissolution, adversely affecting shareholders.
• Liquidity Constraints: As of September 30, 2026, the company has minimal current assets relative to liabilities, with a current ratio of 0.01, indicating limited liquidity to fund operations or pursue transactions without additional financing.
• Market Delisting and Trading: The company voluntarily delisted from Nasdaq and now trades on OTC markets, which may reduce market visibility, liquidity, and investor interest.
• Reliance on Sponsor Funding: The company depends on unsecured promissory notes and extension fees funded by the Sponsor and related parties to maintain operations and extend deadlines, creating dependency risk.
Business trends: The company continues to extend deadlines to complete a business combination while maintaining minimal operational activity and incurring losses.
Execution milestones: Multiple shareholder-approved extensions and termination of a prior business combination agreement; voluntary Nasdaq delisting and OTC trading.
Key risks: Failure to consummate a business combination by final deadlines, liquidity limitations, reliance on Sponsor funding, and reduced market visibility due to OTC trading.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- Horizon Space Acquisition I Corp. is a blank check company incorporated in the Cayman Islands on June 14, 2022, formed to effect a business combination with one or more target businesses without limitation on industry or geography [S1].
- The company completed its IPO on December 27, 2022, issuing 6,900,000 units at $10.00 per unit, raising gross proceeds of $69.0 million, plus a private placement of 385,750 units to the Sponsor for $3.86 million, with proceeds placed in a trust account for the benefit of public shareholders [S1].
- The company has no revenue and has incurred losses since inception due to formation and operating costs [S1].
- The company has entered into multiple business combination agreements and shareholder meeting extensions to complete an initial business combination, with the latest deadline extended to April 27, 2026, subject to further extensions [S1].
- On October 3, 2025, the company terminated a business combination agreement with Squirrel Enlivened Technology Co., Ltd by mutual agreement without termination fees [S1].
- The company has held four shareholder meetings approving extensions to complete a business combination and redeem public shares if no combination is consummated, with corresponding redemption payments made from the trust account [S1].
- The company voluntarily delisted from Nasdaq and began trading on OTC markets under the ticker HSPOF on December 12, 2025 [S1].
- As of September 30, 2026, the company reported current assets of $39,673 and current liabilities of $4,026,538, resulting in a current ratio of 0.01 and a cash ratio of 0.1, indicating limited liquidity [S2].
- The company reported a net loss of $117,601 for the period ending September 30, 2026 [S2].
- The company has issued unsecured promissory notes to the Sponsor totaling $1.8 million for working capital purposes, which bear no interest and are payable upon consummation of a business combination or company expiry [S1].
- The Sponsor and Shenzhen Squirrel have deposited $2.16 million in extension fees into the trust account to extend the deadline for completing a business combination [S1].
Generated 2026-11-17
- S1 | 2026-04-15 | 10-K
- S2 | 2026-11-16 | 10-Q
- N1 | 2026-11-17 | www.nasdaq.com | Neighborhood Intelligence, Inc. Announces $25 Million Share Repurchase Program | https://www.nasdaq.com/articles/neighborhood-intelligence-inc-announces-25-million-share-repurchase-program
- N2 | 2026-11-17 | www.nasdaq.com | Blue Dolphin Energy Company Reports Third Quarter 2026 Financial Results | https://www.nasdaq.com/articles/blue-dolphin-energy-company-reports-third-quarter-2026-financial-results
- N3 | 2026-11-17 | www.nasdaq.com | Guardant Health, Inc. Completes $550 Million Offering of 0% Convertible Senior Notes due 2032 | https://www.nasdaq.com/articles/guardant-health-inc-completes-550-million-offering-0-convertible-senior-notes-due-2032
- N4 | 2026-11-17 | www.nasdaq.com | Research Solutions Reports First Quarter Fiscal Year 2027 Results | https://www.nasdaq.com/articles/research-solutions-reports-first-quarter-fiscal-year-2027-results
- N5 | 2026-11-17 | www.nasdaq.com | Keros Therapeutics, Inc. Announces $5 million Share Repurchase Program Following $20 million Milestone | https://www.nasdaq.com/articles/keros-therapeutics-inc-announces-5-million-share-repurchase-program-following-20-million
- N6 | 2026-11-17 | www.nasdaq.com | Acrivon Therapeutics, Inc. Reports Third Quarter 2026 Financial Results and Business Highlights | https://www.nasdaq.com/articles/acrivon-therapeutics-inc-reports-third-quarter-2026-financial-results-and-business
- N7 | 2026-11-17 | www.nasdaq.com | FibroGen, Inc. Reports Third Quarter 2026 Financial Results | https://www.nasdaq.com/articles/fibrogen-inc-reports-third-quarter-2026-financial-results
- N8 | 2026-11-17 | www.nasdaq.com | Gilead Broadens Ebola Strategy With Obeldesivir Licensing Deals, Remdesivir Agreement Expansion | https://www.nasdaq.com/articles/gilead-broadens-ebola-strategy-obeldesivir-licensing-deals-remdesivir-agreement-expansion
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


